An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy

The large number of emerging antibody-drug conjugates (ADCs) for cancer therapy has resulted in a significant market ‘boom’, garnering worldwide attention. Despite ADCs presenting huge challenges to researchers, particularly regarding the identification of a suitable combination of antibody, linker,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Juliana T. W., Harris, Paul W. R., Brimble, Margaret A., Kavianinia, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510272/
https://www.ncbi.nlm.nih.gov/pubmed/34641391
http://dx.doi.org/10.3390/molecules26195847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510272/
https://www.ncbi.nlm.nih.gov/pubmed/34641391
http://dx.doi.org/10.3390/molecules26195847

Ejemplares similares